Opyl tips revenue growth from partnership with Consentic and its newly launched screening services
Opyl’s flagship platform Opin has made two strategic initiatives that will boost revenue for the company.
“Opyl announced two strategic initiatives that it says will amplify the clinical trial and study enrolment success rate for its Opin platform.”
“The company has formed a strategic partnership with Consentic, an online platform providing video-based electronic clinical trial consent (e-consent).”
“It has also launched a new personalised research screening service that will deliver improved trial enrolment and participant experience.”